These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33752391)

  • 41. Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.
    Chan HL; Thompson A; Martinot-Peignoux M; Piratvisuth T; Cornberg M; Brunetto MR; Tillmann HL; Kao JH; Jia JD; Wedemeyer H; Locarnini S; Janssen HL; Marcellin P
    J Hepatol; 2011 Nov; 55(5):1121-31. PubMed ID: 21718667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of occult hepatitis B virus infection: an update for the clinician.
    Lledó JL; Fernández C; Gutiérrez ML; Ocaña S
    World J Gastroenterol; 2011 Mar; 17(12):1563-8. PubMed ID: 21472122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy.
    Shirvani-Dastgerdi E; Winer BY; Celià-Terrassa T; Kang Y; Tabernero D; Yagmur E; Rodríguez-Frías F; Gregori J; Luedde T; Trautwein C; Ploss A; Tacke F
    J Hepatol; 2017 Aug; 67(2):246-254. PubMed ID: 28392234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New viral biomarkers for Hepatitis B: Are we able to change practice?
    Höner Zu Siederdissen C; Maasoumy B; Cornberg M
    J Viral Hepat; 2018 Nov; 25(11):1226-1235. PubMed ID: 30187603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.
    Hwang JP; Feld JJ; Hammond SP; Wang SH; Alston-Johnson DE; Cryer DR; Hershman DL; Loehrer AP; Sabichi AL; Symington BE; Terrault N; Wong ML; Somerfield MR; Artz AS
    J Clin Oncol; 2020 Nov; 38(31):3698-3715. PubMed ID: 32716741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
    Fung J; Lai CL; Young J; Wong DK; Yuen J; Seto WK; Yuen MF
    Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Update on hepatitis B virus infection.
    You CR; Lee SW; Jang JW; Yoon SK
    World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B.
    Leung RH; Hui RW; Mak LY; Mao X; Liu KS; Wong DK; Fung J; Seto WK; Yuen MF
    J Hepatol; 2024 Aug; 81(2):218-226. PubMed ID: 38527527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of hepatitis B: Is there still a role for interferon?
    Viganò M; Grossi G; Loglio A; Lampertico P
    Liver Int; 2018 Feb; 38 Suppl 1():79-83. PubMed ID: 29427498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of HBsAg quantification for monitoring natural history and treatment outcome.
    Martinot-Peignoux M; Lapalus M; Asselah T; Marcellin P
    Liver Int; 2013 Feb; 33 Suppl 1():125-32. PubMed ID: 23286856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver-Humanized NSG-PiZ Mice Support the Study of Chronic Hepatitis B Virus Infection and Antiviral Therapies.
    Colón-Thillet R; Stone D; Loprieno MA; Klouser L; Roychoudhury P; Santo TK; Xie H; Stensland L; Upham SL; Pepper G; Huang ML; Aubert M; Jerome KR
    Microbiol Spectr; 2023 Jun; 11(3):e0517622. PubMed ID: 37199630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis B surface antigen monitoring and management of chronic hepatitis B.
    Sonneveld MJ; Zoutendijk R; Janssen HL
    J Viral Hepat; 2011 Jul; 18(7):449-57. PubMed ID: 21692954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era.
    Mak JWY; Law AWH; Law KWT; Ho R; Cheung CKM; Law MF
    World J Gastroenterol; 2023 Sep; 29(33):4942-4961. PubMed ID: 37731995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Very Young Adult Female Patient with Hepatitis B Flare: A Case Report.
    Kurniawan AA; Maimunah U
    Acta Med Indones; 2023 Jul; 55(3):320-326. PubMed ID: 37915151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.
    Patel A; Yapali S; Lok AS
    Hepatol Int; 2016 Jan; 10(1):139-46. PubMed ID: 26272106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The enrichment of HBV immune-escape mutations during nucleoside/nucleotide analogue therapy.
    Shan M; Shen Z; Sun H; Zheng J; Zhang M
    Antivir Ther; 2017; 22(8):717-720. PubMed ID: 28300730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study.
    Lee JH; Lee YB; Cho EJ; Yu SJ; Yoon JH; Kim YJ
    Clin Infect Dis; 2021 Nov; 73(9):e3308-e3316. PubMed ID: 32556157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunosuppression and HBV reactivation.
    Shouval D; Shibolet O
    Semin Liver Dis; 2013 May; 33(2):167-77. PubMed ID: 23749673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
    Fung J; Lai CL; Yuen MF
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associations of HBV Genotype B vs C Infection With Relapse After Cessation of Entecavir or Tenofovir Therapy.
    Chiu SM; Kuo YH; Wang JH; Hung CH; Hu TH; Lu SN; Chen CH
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2989-2997.e3. PubMed ID: 32353534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.